Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Bruker Launches New FT-IR R&D Spectrometer INVENIO™

Bruker Corporation
Posted on: 10 Apr 18
Bruker Launches New FT-IR R&D Spectrometer INVENIO™

PR Newswire

MUNICH, April 10, 2018

MUNICH, April 10, 2018 /PRNewswire/ -- At Analytica 2018, Bruker today announces the launch of the new INVENIO™ Fourier Transform Infrared (FT-IR) research spectrometer.  The INVENIO is the successor to the renowned VERTEX 70 FT-IR for advanced R&D applications.  

The novel INVENIO combines many innovations with proven Vertex 70 technologies, such as unique FM technology for simultaneous mid and far IR spectroscopy.  The new MultiTect™ technology allows for control of up to five internal detectors, covering the spectral range from far infrared to Vis/UV.  A DigiTect™ detector slot enables additional flexibility for even more detectors. The smart INVENIO beam path further improves optical throughput and spectroscopic sensitivity.

In addition to performance and flexibility, a major goal of the INVENIO is to simplify the research user's experience.  An integrated touch panel enables intuitive configuration set-ups and workflows for R&D applications, and the system can also be switched to notebook operation.  The Transit™ channel allows for easy transmission measurements, without removing experiments from the sample compartment. 

The INVENIO is an intelligent spectrometer with many exciting features that set it apart from other research FT-IRs. These include electronically coded beam windows with magnetic mount, an automated internal attenuator wheel and an 8-position validation wheel for standards and customer-specific filters.  The unique Bruker Rocksolid™ interferometer and FM technology for simultaneous mid and far IR complete the INVENIO feature set.

About Bruker Corporation (NASDAQ: BRKR)

For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life.  Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.  In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy, nanoanalysis and industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research, clinical microbiology and molecular pathology research. For more information, please visit

For more information on INVENIO, please visit:

Media Contact:

Investor Contact:

Michael Mueller

Miroslava Minkova

Marketing Manager

Head of Investor Relations

Bruker Optics

Bruker Corporation

T: +49 (7243) 504-2652

T: +1 (978) 663-3660, ext. 1479





View original content with multimedia:

SOURCE Bruker Corporation

PR Newswire

Last updated on: 10/04/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.